Literature DB >> 20951969

miR-146a mediates protective innate immune tolerance in the neonate intestine.

Cécilia Chassin1, Magdalena Kocur, Johanna Pott, Claudia U Duerr, Dominique Gütle, Michael Lotz, Mathias W Hornef.   

Abstract

After birth, the intestinal mucosa undergoes a dramatic transition from a sterile protected site to an environmentally exposed and permanently colonized surface. The mechanisms that facilitate this transition are ill defined. Here, we demonstrate that microRNA-146a-mediated translational repression and proteolytic degradation of the essential Toll-like receptor (TLR) signaling molecule interleukin 1 receptor associated kinase 1 (IRAK1) is sufficient to induce intestinal epithelial innate immune tolerance and provide protection from bacteria-induced epithelial damage in neonates. Despite low IRAK1 protein levels, continuous TLR4- and IRAK1-dependent signal transduction induced by intraepithelial endotoxin persistence during the neonatal period maintains tolerance through sustained miR-146a expression. Strikingly, it additionally facilitates transcription of a distinct set of genes involved in cell survival, differentiation, and homeostasis. Thus, our results identify the underlying molecular mechanisms of intestinal epithelial innate immune tolerance during the neonatal period and characterize tolerance as an active condition involved in the establishment of intestinal mucosal homeostasis.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20951969     DOI: 10.1016/j.chom.2010.09.005

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  85 in total

Review 1.  The impact of perinatal immune development on mucosal homeostasis and chronic inflammation.

Authors:  Harald Renz; Per Brandtzaeg; Mathias Hornef
Journal:  Nat Rev Immunol       Date:  2011-12-09       Impact factor: 53.106

2.  Between vigilance and tolerance: the immune function of the intestinal epithelium.

Authors:  Cécilia Chassin; Mathias W Hornef
Journal:  Cell Mol Life Sci       Date:  2011-10-04       Impact factor: 9.261

Review 3.  Expression and functional importance of innate immune receptors by intestinal epithelial cells.

Authors:  Rute Marques; Ivo G Boneca
Journal:  Cell Mol Life Sci       Date:  2011-10-08       Impact factor: 9.261

Review 4.  Establishment of intestinal homeostasis during the neonatal period.

Authors:  Silvia Stockinger; Mathias W Hornef; Cécilia Chassin
Journal:  Cell Mol Life Sci       Date:  2011-09-28       Impact factor: 9.261

5.  (micro)Tolerance in the gut.

Authors:  Olive Leavy
Journal:  Nat Rev Immunol       Date:  2010-12       Impact factor: 53.106

6.  Gut immune maturation depends on colonization with a host-specific microbiota.

Authors:  Hachung Chung; Sünje J Pamp; Jonathan A Hill; Neeraj K Surana; Sanna M Edelman; Erin B Troy; Nicola C Reading; Eduardo J Villablanca; Sen Wang; Jorge R Mora; Yoshinori Umesaki; Diane Mathis; Christophe Benoist; David A Relman; Dennis L Kasper
Journal:  Cell       Date:  2012-06-22       Impact factor: 41.582

Review 7.  Neonatal immunology: responses to pathogenic microorganisms and epigenetics reveal an "immunodiverse" developmental state.

Authors:  Becky Adkins
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

Review 8.  MicroRNAs: the fine-tuners of Toll-like receptor signalling.

Authors:  Luke A O'Neill; Frederick J Sheedy; Claire E McCoy
Journal:  Nat Rev Immunol       Date:  2011-02-18       Impact factor: 53.106

Review 9.  Unique aspects of the perinatal immune system.

Authors:  Xiaoming Zhang; Dania Zhivaki; Richard Lo-Man
Journal:  Nat Rev Immunol       Date:  2017-06-19       Impact factor: 53.106

10.  Toll-like receptor-deficient mice reveal how innate immune signaling influences Salmonella virulence strategies.

Authors:  Kelsey E Sivick; Nicholas Arpaia; Gabrielle L Reiner; Bettina L Lee; Bethany R Russell; Gregory M Barton
Journal:  Cell Host Microbe       Date:  2014-02-12       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.